Fisher & Paykel Healthcare Corporation Limited
FSPKF
$20.56
-$1.00-4.64%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.02% | 11.89% | 12.72% | 11.98% | 10.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.02% | 11.89% | 12.72% | 11.98% | 10.45% |
| Cost of Revenue | 2.48% | 3.97% | 4.47% | 6.43% | 7.74% |
| Gross Profit | 14.91% | 17.10% | 18.24% | 15.71% | 12.28% |
| SG&A Expenses | 4.33% | 5.46% | 5.49% | 7.95% | 9.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.52% | 5.19% | 5.81% | 7.76% | 9.03% |
| Operating Income | 32.83% | 36.73% | 39.90% | 28.14% | 15.75% |
| Income Before Tax | 85.52% | 96.05% | 106.80% | 33.15% | -15.82% |
| Income Tax Expenses | 12.54% | 15.82% | 18.70% | 25.19% | 31.36% |
| Earnings from Continuing Operations | 135.81% | 154.51% | 175.11% | 37.08% | -32.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 135.81% | 154.51% | 175.11% | 37.08% | -32.52% |
| EBIT | 32.83% | 36.73% | 39.90% | 28.14% | 15.75% |
| EBITDA | 28.57% | 32.59% | 35.87% | 27.35% | 17.87% |
| EPS Basic | 135.11% | 153.31% | 173.03% | 35.84% | -33.11% |
| Normalized Basic EPS | 39.50% | 42.83% | 45.31% | 27.80% | 10.69% |
| EPS Diluted | 135.27% | 153.25% | 172.83% | 35.58% | -33.33% |
| Normalized Diluted EPS | 39.42% | 42.73% | 45.18% | 27.69% | 10.54% |
| Average Basic Shares Outstanding | 0.38% | 0.50% | 0.61% | 0.69% | 0.77% |
| Average Diluted Shares Outstanding | 0.43% | 0.56% | 0.69% | 0.77% | 0.85% |
| Dividend Per Share | -1.53% | -0.55% | -0.59% | 0.79% | 1.43% |
| Payout Ratio | -0.30% | -0.40% | -0.50% | -0.17% | 0.39% |